Selected research
Industry Research
Piroxicam Oral Tablets Industry Research Report 2026
Market perspective
The global Piroxicam Oral Tablets market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Piroxicam Oral Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Piroxicam Oral Tablets is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Piroxicam Oral Tablets is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Piroxicam Oral Tablets include Yunpeng Pharmaceutical Group, Shandong Fangming Pharmaceutical Group, Wanrong Pharmaceutical (Langzhi Group), Nantong Jinghua Pharmaceutical, Wellona Pharma, SK Chemical, Pfizer, Chr. Olesen Group and Adva Care Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Piroxicam Oral Tablets market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Piroxicam Oral Tablets Market by Company
Yunpeng Pharmaceutical Group
Shandong Fangming Pharmaceutical Group
Wanrong Pharmaceutical (Langzhi Group)
Nantong Jinghua Pharmaceutical
Wellona Pharma
SK Chemical
Pfizer
Chr. Olesen Group
Adva Care Pharma
Piroxicam Oral Tablets Segment by Type
Regular Release Tablets
Modified Release Tablets
Piroxicam Oral Tablets Segment by Application
Hospital
Clinic
Pharmacy
Piroxicam Oral Tablets Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Piroxicam Oral Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Piroxicam Oral Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Piroxicam Oral Tablets.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Piroxicam Oral Tablets manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Piroxicam Oral Tablets by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Piroxicam Oral Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Regular Release Tablets
- Modified Release Tablets
Applications
- Hospital
- Clinic
- Pharmacy
Companies covered
- Yunpeng Pharmaceutical Group
- Shandong Fangming Pharmaceutical Group
- Wanrong Pharmaceutical (Langzhi Group)
- Nantong Jinghua Pharmaceutical
- Wellona Pharma
- SK Chemical
- Pfizer
- Chr. Olesen Group
- Adva Care Pharma
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Piroxicam Oral Tablets Market Size (2021-2032)
- 2.2.2 Global Piroxicam Oral Tablets Sales (2021-2032)
- 2.2.3 Global Piroxicam Oral Tablets Market Average Price (2021-2032)
- 2.3 Piroxicam Oral Tablets by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Regular Release Tablets
- 2.3.3 Modified Release Tablets
- 2.4 Piroxicam Oral Tablets by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital
- 2.4.3 Clinic
- 2.4.4 Pharmacy
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Piroxicam Oral Tablets Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Piroxicam Oral Tablets Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Piroxicam Oral Tablets Revenue of Manufacturers (2021-2026)
- 3.4 Global Piroxicam Oral Tablets Average Price by Manufacturers (2021-2026)
- 3.5 Global Piroxicam Oral Tablets Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Piroxicam Oral Tablets, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Piroxicam Oral Tablets, Product Type & Application
- 3.8 Global Manufacturers of Piroxicam Oral Tablets, Established Date
- 3.9 Global Piroxicam Oral Tablets Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Yunpeng Pharmaceutical Group
- 4.1.1 Yunpeng Pharmaceutical Group Company Information
- 4.1.2 Yunpeng Pharmaceutical Group Business Overview
- 4.1.3 Yunpeng Pharmaceutical Group Piroxicam Oral Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Yunpeng Pharmaceutical Group Piroxicam Oral Tablets Product Portfolio
- 4.1.5 Yunpeng Pharmaceutical Group Recent Developments
- 4.2 Shandong Fangming Pharmaceutical Group
- 4.2.1 Shandong Fangming Pharmaceutical Group Company Information
- 4.2.2 Shandong Fangming Pharmaceutical Group Business Overview
- 4.2.3 Shandong Fangming Pharmaceutical Group Piroxicam Oral Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Shandong Fangming Pharmaceutical Group Piroxicam Oral Tablets Product Portfolio
- 4.2.5 Shandong Fangming Pharmaceutical Group Recent Developments
- 4.3 Wanrong Pharmaceutical (Langzhi Group)
- 4.3.1 Wanrong Pharmaceutical (Langzhi Group) Company Information
- 4.3.2 Wanrong Pharmaceutical (Langzhi Group) Business Overview
- 4.3.3 Wanrong Pharmaceutical (Langzhi Group) Piroxicam Oral Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Wanrong Pharmaceutical (Langzhi Group) Piroxicam Oral Tablets Product Portfolio
- 4.3.5 Wanrong Pharmaceutical (Langzhi Group) Recent Developments
- 4.4 Nantong Jinghua Pharmaceutical
- 4.4.1 Nantong Jinghua Pharmaceutical Company Information
- 4.4.2 Nantong Jinghua Pharmaceutical Business Overview
- 4.4.3 Nantong Jinghua Pharmaceutical Piroxicam Oral Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Nantong Jinghua Pharmaceutical Piroxicam Oral Tablets Product Portfolio
- 4.4.5 Nantong Jinghua Pharmaceutical Recent Developments
- 4.5 Wellona Pharma
- 4.5.1 Wellona Pharma Company Information
- 4.5.2 Wellona Pharma Business Overview
- 4.5.3 Wellona Pharma Piroxicam Oral Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Wellona Pharma Piroxicam Oral Tablets Product Portfolio
- 4.5.5 Wellona Pharma Recent Developments
- 4.6 SK Chemical
- 4.6.1 SK Chemical Company Information
- 4.6.2 SK Chemical Business Overview
- 4.6.3 SK Chemical Piroxicam Oral Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 SK Chemical Piroxicam Oral Tablets Product Portfolio
- 4.6.5 SK Chemical Recent Developments
- 4.7 Pfizer
- 4.7.1 Pfizer Company Information
- 4.7.2 Pfizer Business Overview
- 4.7.3 Pfizer Piroxicam Oral Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Pfizer Piroxicam Oral Tablets Product Portfolio
- 4.7.5 Pfizer Recent Developments
- 4.8 Chr. Olesen Group
- 4.8.1 Chr. Olesen Group Company Information
- 4.8.2 Chr. Olesen Group Business Overview
- 4.8.3 Chr. Olesen Group Piroxicam Oral Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Chr. Olesen Group Piroxicam Oral Tablets Product Portfolio
- 4.8.5 Chr. Olesen Group Recent Developments
- 4.9 Adva Care Pharma
- 4.9.1 Adva Care Pharma Company Information
- 4.9.2 Adva Care Pharma Business Overview
- 4.9.3 Adva Care Pharma Piroxicam Oral Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Adva Care Pharma Piroxicam Oral Tablets Product Portfolio
- 4.9.5 Adva Care Pharma Recent Developments
5 Global Piroxicam Oral Tablets Market Scenario by Region
- 5.1 Global Piroxicam Oral Tablets Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Piroxicam Oral Tablets Sales by Region: 2021-2032
- 5.2.1 Global Piroxicam Oral Tablets Sales by Region: 2021-2026
- 5.2.2 Global Piroxicam Oral Tablets Sales by Region: 2027-2032
- 5.3 Global Piroxicam Oral Tablets Revenue by Region: 2021-2032
- 5.3.1 Global Piroxicam Oral Tablets Revenue by Region: 2021-2026
- 5.3.2 Global Piroxicam Oral Tablets Revenue by Region: 2027-2032
- 5.4 North America Piroxicam Oral Tablets Market Facts & Figures by Country
- 5.4.1 North America Piroxicam Oral Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Piroxicam Oral Tablets Sales by Country (2021-2032)
- 5.4.3 North America Piroxicam Oral Tablets Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Piroxicam Oral Tablets Market Facts & Figures by Country
- 5.5.1 Europe Piroxicam Oral Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Piroxicam Oral Tablets Sales by Country (2021-2032)
- 5.5.3 Europe Piroxicam Oral Tablets Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Piroxicam Oral Tablets Market Facts & Figures by Country
- 5.6.1 Asia Pacific Piroxicam Oral Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Piroxicam Oral Tablets Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Piroxicam Oral Tablets Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Piroxicam Oral Tablets Market Facts & Figures by Country
- 5.7.1 South America Piroxicam Oral Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Piroxicam Oral Tablets Sales by Country (2021-2032)
- 5.7.3 South America Piroxicam Oral Tablets Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.7.7 Colombia
- 5.8 Middle East and Africa Piroxicam Oral Tablets Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Piroxicam Oral Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Piroxicam Oral Tablets Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Piroxicam Oral Tablets Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Piroxicam Oral Tablets Sales by Type (2021-2032)
- 6.1.1 Global Piroxicam Oral Tablets Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Piroxicam Oral Tablets Sales Market Share by Type (2021-2032)
- 6.2 Global Piroxicam Oral Tablets Revenue by Type (2021-2032)
- 6.2.1 Global Piroxicam Oral Tablets Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Piroxicam Oral Tablets Revenue Market Share by Type (2021-2032)
- 6.3 Global Piroxicam Oral Tablets Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Piroxicam Oral Tablets Sales by Application (2021-2032)
- 7.1.1 Global Piroxicam Oral Tablets Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Piroxicam Oral Tablets Sales Market Share by Application (2021-2032)
- 7.2 Global Piroxicam Oral Tablets Revenue by Application (2021-2032)
- 7.2.1 Global Piroxicam Oral Tablets Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Piroxicam Oral Tablets Revenue Market Share by Application (2021-2032)
- 7.3 Global Piroxicam Oral Tablets Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Piroxicam Oral Tablets Value Chain Analysis
- 8.1.1 Piroxicam Oral Tablets Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Piroxicam Oral Tablets Production Mode & Process
- 8.2 Piroxicam Oral Tablets Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Piroxicam Oral Tablets Distributors
- 8.2.3 Piroxicam Oral Tablets Customers
9 Global Piroxicam Oral Tablets Analyzing Market Dynamics
- 9.1 Piroxicam Oral Tablets Industry Trends
- 9.2 Piroxicam Oral Tablets Industry Drivers
- 9.3 Piroxicam Oral Tablets Industry Opportunities and Challenges
- 9.4 Piroxicam Oral Tablets Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst